New diabetes clinical trial: IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
Published on: September 26, 2024 at 11:00PM
Conditions: Wound Heal; Ulcer
Interventions: Device: InnovaMatrix® AC
Sponsors: ConvaTec Inc.
Not yet recruiting
https://ift.tt/XGsyaFp
Conditions: Wound Heal; Ulcer
Interventions: Device: InnovaMatrix® AC
Sponsors: ConvaTec Inc.
Not yet recruiting
https://ift.tt/XGsyaFp
Comments
Post a Comment